• OPEN AN ACCOUNT
Indian Indices
Sensex
83,919.71 897.96
( 1.08%)
Global Indices
Nasdaq
48,502.41 -615.65
(-1.25%)
Dow Jones
6,987.82 -209.01
(-2.90%)
Hang Seng
56,657.02 -2,787.19
(-4.69%)
Nikkei 225
10,369.59 -83.09
(-0.79%)
Forex
USD-INR
93.34 -0.08
(-0.09%)
EUR-INR
102.47 -0.06
(-0.06%)
GBP-INR
122.55 -0.48
(-0.39%)
JPY-INR
0.58 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Rajnish Wellness Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541601
INE685Z01033
1.0145172
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
45.69
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

ltm ltd
Aarti Industries inks long term manufacturing and supply agreement of USD 150 million
Oct 13,2026

Aarti Industries (AIL) announced that it has entered into a 10+ year dedicated manufacturing and supply agreement with a leading global speciality chemical company serving diverse industries with a cumulative revenue potential of approximately Rs 1500 crore (about US$150 million) over its contract term.

AIL will set up, commission, and operate a dedicated manufacturing facility in India for a speciality chemical used in high-performance applications, based on the customer's proprietary process technology and a structured financial arrangement to finance CAPEX of less than US$25 million.

The model combines global technology with AIL's process scale-up, engineering, and operating capabilities to provide a critical manufacturing outsourcing solution to global companies. Commercial operations are expected to commence in FY2028–29, subject to applicable approvals.

By localising manufacturing through a dedicated Indian setup, this arrangement will support supply-chain resilience and the customer's growth plans in India. For AIL, the agreement broadens its global customer base, strengthens its strategic manufacturing portfolio and creates a platform to deepen the relationship as the customer's India requirements grow.